Danske Bank’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.42M Buy
68,645
+68,345
+22,782% +$5.81M 0.01% 520
2026
Q1
$25.8K Sell
300
-1,100
-79% -$98.7K ﹤0.01% 722
2025
Q4
$122K Sell
1,400
-9,140
-87% -$694K ﹤0.01% 740
2025
Q3
$604K Sell
10,540
-12,107
-53% -$697K ﹤0.01% 757
2025
Q2
$1.34M Sell
22,647
-6,451
-22% -$417K ﹤0.01% 676
2025
Q1
$2.13M Buy
29,098
+369
+1% +$30.5K 0.01% 646
2024
Q4
$2.38M Buy
28,729
+17,414
+154% +$1.37M 0.01% 618
2024
Q3
$809K Buy
11,315
+3,285
+41% +$232K ﹤0.01% 846
2024
Q2
$550K Buy
+8,030
New +$480K ﹤0.01% 854

Other funds holding GMED

Danske Bank's GMED Position: Q2 2026 in Review

Danske Bank increased its Globus Medical (GMED) stake by 22,782% in Q2 2026, buying an estimated $5.81M and bringing the position to 68,645 shares worth $5.42M. The position accounts for 0.01% of the portfolio, ranked #520.

Danske Bank first reported a position in GMED in Q2 2024 and has held it in 9 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Danske Bank held 68,645 shares of Globus Medical worth $5.42M as of Q2 2026.
  • Danske Bank bought 68,345 Globus Medical shares in Q2 2026, an estimated $5.81M.
  • Globus Medical made up 0.01% of Danske Bank's portfolio in Q2 2026, its #520 holding.
  • Danske Bank first reported a position in Globus Medical in Q2 2024 and has held it in 9 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.